We are live on ! Find out more
MC

Marcus Capital Portfolio holdings

AUM $34.3M
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+30.44%
3 Year Est. Return
+101.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$104M
AUM Growth
+$9.08M
Cap. Flow
-$318K
Cap. Flow %
-0.31%
Top 10 Hldgs %
36.42%
Holding
52
New
1
Increased
27
Reduced
16
Closed
1

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$824K
2
P
Everpure Inc
P
+$747K
3
ACHN
Achillion Pharmaceuticals
ACHN
+$638K
4
DATA
Tableau Software, Inc.
DATA
+$568K
5
CMG icon
Chipotle Mexican Grill
CMG
+$421K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.42M
2
MDVN
MEDIVATION, INC.
MDVN
+$708K
3
CELG
Celgene Corp
CELG
+$557K
4
TWTR
Twitter, Inc.
TWTR
+$484K
5
WFM
Whole Foods Market Inc
WFM
+$307K

Sector Composition

Rank Sector Weight
1 Technology 23.7%
2 Consumer Discretionary 20.99%
3 Financials 12.4%
4 Healthcare 10.45%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
51
Pfizer
PFE
$143B
$220K 0.21%
6,851
+105
+2% +$3.51K
BIIB icon
52
Biogen
BIIB
$30.4B
– –
-10,000
Closed -$2.42M
1 2
3

Similar funds

PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
RIA
Rocaton Investment Advisors Norwalk, Connecticut $36.6M AUM 10.31% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
IP
Ironsides Partners Boston, Massachusetts $27.7M AUM 1.11% 1-Year Est. Return
DCM
Dearborn Capital Management Chicago, Illinois $41.6M AUM 2.79% 1-Year Est. Return
PA
Pastel & Associes Paris, France $43.8M AUM 18.14% 1-Year Est. Return
P
PhaseCapital New York $45.2M AUM 8.85% 1-Year Est. Return
MCAI
Meritech Capital Associates III Palo Alto, California $45.8M AUM 24.9% 1-Year Est. Return

Marcus Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Marcus Capital held 52 positions worth $104M, up 9.6% from $95M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Trading was light in Q3 2016: portfolio turnover was 3.8%. Marcus Capital opened 1 new position and exited 1, leaving the 52-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marcus Capital's largest Q3 2016 buy was Achillion Pharmaceuticals: 75,000 shares worth $608K.
  • Marcus Capital added most to Costco in Q3 2016, an estimated $824K increase.
  • Marcus Capital's biggest Q3 2016 reduction was MEDIVATION, INC., cutting an estimated $708K.
  • Marcus Capital fully exited Biogen in Q3 2016, selling an estimated $2.42M.
  • Marcus Capital's ten largest holdings make up 36% of its $104M portfolio in Q3 2016.
  • Marcus Capital opened 1 new position and closed 1 in Q3 2016.
  • Marcus Capital's portfolio value rose 9.6% quarter-over-quarter to $104M.

Based on Marcus Capital's 13F filing for Q3 2016, filed 8 Nov 2016.